Product profile
Glempa-M
Empagliflozin + Metformin Hydrochloride
Product overview
Regulatory-friendly overview of dosage forms and commercial presentations.
This page summarizes the current product entry from the supplied catalogue source.
Active ingredient
Empagliflozin + Metformin Hydrochloride
Therapeutic area
Hypoglycemics
Available dosage forms
Tablet
Available strengths
5mg + 500mg; 5mg + 850mg; 5mg + 1000mg; 12.5mg + 500mg; 12.5mg + 850mg; 12.5mg + 1000mg
Pack sizes
14’s
Presentations
1
Regulatory note
This catalogue is informational only. Pricing, promotional claims, and market-specific availability are not shown.
Catalogue access
Need the complete portfolio? Download the source file used for this catalogue.
Commercial presentations
Glempa-M
Available strengths and pack sizes are listed below exactly as provided in the source file.
| Therapeutic area | Generic | Dosage form | Strength | Pack size |
|---|---|---|---|---|
| Hypoglycemics | Empagliflozin + Metformin Hydrochloride | Tablet | 5mg + 500mg; 5mg + 850mg; 5mg + 1000mg; 12.5mg + 500mg; 12.5mg + 850mg; 12.5mg + 1000mg | 14’s |